Retatrutide (LY3437943) is a high-purity peptide compound designed for research applications in metabolic disorders. This innovative triple agonist simultaneously targets glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R), making it particularly valuable for studies in obesity and type 2 diabetes.
The peptide demonstrates exceptional binding affinity with EC50 values of 5.79 nM for GCGR, 0.0643 nM for GIPR, and 0.775 nM for GLP-1R. These characteristics make LY3437943 an important tool for investigating energy expenditure mechanisms and metabolic regulation pathways.
Our Retatrutide peptide site material undergoes rigorous quality control testing to ensure batch-to-batch consistency. The white powder form is supplied in sealed vials to maintain stability and purity throughout your research timeline.
For research use only. Not intended for diagnostic or therapeutic applications in humans.